Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001663577-21-000147
Filing Date
2021-03-26
Accepted
2021-03-25 19:12:21
Documents
46
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 abti10k.htm 10-K 535430
2 ex31_1.htm EX-31.1 8998
3 ex31_2.htm EX-31.2 8999
4 ex32_1.htm EX-32.1 3963
5 GRAPHIC image_001.gif GRAPHIC 5157
6 GRAPHIC image_001.jpg GRAPHIC 1846
  Complete submission text file 0001663577-21-000147.txt   1802880

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE abti-20190930.xml EX-101.INS 172695
8 XBRL SCHEMA FILE abti-20190930.xsd EX-101.SCH 19335
9 XBRL CALCULATION FILE abti-20190930_cal.xml EX-101.CAL 21129
10 XBRL DEFINITION FILE abti-20190930_def.xml EX-101.DEF 54883
11 XBRL LABEL FILE abti-20190930_lab.xml EX-101.LAB 144876
12 XBRL PRESENTATION FILE abti-20190930_pre.xml EX-101.PRE 129953
Mailing Address 340 S. LEMON AVE., #4041 WALNUT CA 91789
Business Address 340 S. LEMON AVE., #4041 WALNUT CA 91789 909-584-5853
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-156091 | Film No.: 21774015
SIC: 1000 Metal Mining